{"id":"d5453fdf-00bb-5918-bc13-982317d9fb1e","stable_key":"5d8e27d8-6a74-5560-827f-3f90908bbc34:ala-ascorbate-peroxide-antagonism","predicate":"dampens","statement":"Lipoic acid reduced pharmacological ascorbate-generated hydrogen peroxide in the tested cell experiments.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"d1b95bec-3551-5f43-81fb-ac7e1f140629","mechanism_event_label":"Reducing an oxidant can oppose a treatment that relies on that oxidant.","subject":{"id":"ab091982-3acb-5a87-80fb-85dfe292c1e0","slug":"lipoic-acid","display_name":"Lipoic acid","entity_type_key":"small_molecule"},"object":{"id":"462ef2d4-5364-5d4c-99a8-31c8f7d0b713","slug":"ascorbate-generated-hydrogen-peroxide","display_name":"Extracellular hydrogen peroxide generated by pharmacological ascorbate","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d1b95bec-3551-5f43-81fb-ac7e1f140629","stable_key":"5d8e27d8-6a74-5560-827f-3f90908bbc34:ala-ascorbate-peroxide-antagonism-event","event_type":"biochemical_relationship","label":"Reducing an oxidant can oppose a treatment that relies on that oxidant.","description":"Lipoic acid reduced pharmacological ascorbate-generated hydrogen peroxide in the tested cell experiments.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"38d0c4d9-53d1-5239-bfe3-c1b5e9b79085","slug":"ascorbate","display_name":"L-Ascorbate","entity_type_key":"small_molecule"},"role":"oxidant_generating_exposure","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"ab091982-3acb-5a87-80fb-85dfe292c1e0","slug":"lipoic-acid","display_name":"Lipoic acid","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"462ef2d4-5364-5d4c-99a8-31c8f7d0b713","slug":"ascorbate-generated-hydrogen-peroxide","display_name":"Extracellular hydrogen peroxide generated by pharmacological ascorbate","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/ala-research/39493360.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"9bd9ced1ace4214d80aad8e15ca5d61f8e4063f4e5838054b93e8c07a9550266\", \"start_char\": 0, \"end_char\": 1935, \"text_sha256\": \"9bd9ced1ace4214d80aad8e15ca5d61f8e4063f4e5838054b93e8c07a9550266\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Cancer-cell combinations and human-tumor xenograft experiments","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Millimolar cell exposures; injected ALA/ascorbate combinations in mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Pharmacological ascorbate and animal injection exposures are not dietary vitamin C; no clinical combination trial.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"lipoic-acid","display_name":"Lipoic acid","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human cancer cells and mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Reducing an oxidant can oppose a treatment that relies on that oxidant.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[ala-p39493360] Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models. (2024). https://pubmed.ncbi.nlm.nih.gov/39493360/ DOI: 10.1177/11795549241283421","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Six cell lines; MDA-MB-231 xenografts","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"197b5621-c00f-5c5d-9913-9cebcb363464","evidence_kind":"source_excerpt","locator":"Lines 1079-1090","start_line":1079,"end_line":1090,"excerpt":"### ala-ascorbate-peroxide-antagonism\nLipoic acid reduced pharmacological ascorbate-generated hydrogen peroxide in the tested cell experiments.\nCondition category: normal\nnutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Reducing an oxidant can oppose a treatment that relies on that oxidant.\norganism: Human cancer cells and mice\ntissue_or_cell_type: Six cell lines; MDA-MB-231 xenografts\nexperimental_model: Cancer-cell combinations and human-tumor xenograft experiments\nlimitations: Pharmacological ascorbate and animal injection exposures are not dietary vitamin C; no clinical combination trial.\nexposure: Millimolar cell exposures; injected ALA/ascorbate combinations in mice\nevidence_span: {\"source_cache\": \"artifacts/ala-research/39493360.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"9bd9ced1ace4214d80aad8e15ca5d61f8e4063f4e5838054b93e8c07a9550266\", \"start_char\": 0, \"end_char\": 1935, \"text_sha256\": \"9bd9ced1ace4214d80aad8e15ca5d61f8e4063f4e5838054b93e8c07a9550266\"}\n[ala-p39493360] Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models. (2024). https://pubmed.ncbi.nlm.nih.gov/39493360/ DOI: 10.1177/11795549241283421","model_system":"Cancer-cell combinations and human-tumor xenograft experiments","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [ala-p39493360] Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models. (2024). https://pubmed.ncbi.nlm.nih.gov/39493360/ DOI: 10.1177/11795549241283421","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d8afa8c2-ced9-5b28-90ca-2ac120ec7202","stable_key":"import-5d8e27d8-6a74-5560-827f-3f90908bbc34","title":"Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"611da198ab85a272eb26b64ee330ef6d1a762853a8481f3191c4acfca9f3cf3d","revision_id":"618b4ce6-3157-5222-8325-408064be5ea5","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}